603108.SS SHH
Shanghai Runda Medical Technology Co., Ltd.
1W: -2.0%
1M: +1.0%
3M: +7.2%
YTD: -40.0%
1Y: -45.7%
3Y: -31.7%
5Y: -7.1%
¥9.97 ($1.49)
-0.11 (-1.09%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$8.3B
-9.1% ▼
5Y CAGR: +3.3%
Gross Profit
$2.1B
-13.0% ▼
5Y CAGR: +1.9%
Operating Income
$354M
-45.3% ▼
5Y CAGR: -12.2%
Net Income
$55M
-79.8% ▼
5Y CAGR: -29.1%
EPS (Diluted)
$0.09
-80.9% ▼
5Y CAGR: -30.0%
EBITDA
$873M
-15.3% ▼
5Y CAGR: -4.0%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $7.1B | $8.9B | $10.5B | $9.1B | $8.3B |
| YoY Growth | +0.2% | +25.3% | +18.4% | -12.8% | -9.1% |
| Cost of Revenue | $5.2B | $6.5B | $7.6B | $6.7B | $6.2B |
| Gross Profit | $1.9B | $2.4B | $2.9B | $2.4B | $2.1B |
| Gross Margin | 27.0% | 27.0% | 27.9% | 26.4% | 25.3% |
| R&D Expenses | $87M | $123M | $146M | $147M | $116M |
| SG&A Expenses | $1.0B | $1.2B | $1.6B | $1.4B | $1.3B |
| Operating Expenses | $1.3B | $1.6B | $2.1B | $1.8B | $1.7B |
| Operating Income | $644M | $778M | $816M | $647M | $354M |
| Operating Margin | 9.1% | 8.8% | 7.8% | 7.1% | 4.3% |
| Interest Expense | $255M | $291M | $330M | $334M | $321M |
| Income Before Tax | $636M | $780M | $820M | $656M | $346M |
| Tax Expense | $132M | $182M | $165M | $213M | $156M |
| Net Income | $330M | $380M | $418M | $273M | $55M |
| Net Margin | 4.7% | 4.3% | 4.0% | 3.0% | 0.7% |
| EPS (Diluted) | $0.57 | $0.64 | $0.70 | $0.47 | $0.09 |
| EBITDA | $1.0B | $1.2B | $1.3B | $1.0B | $873M |
| Shares Outstanding | 580M | 594M | 597M | 581M | 614M |